On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London.

Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite drug discovery.

Confirmed speakers include:

  • Nikhil Gupta, Principal Scientist at the Cancer Research Horizons- AstraZeneca Functional Genomics Centre
  • Chas Bountra, Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University
  • Lawrence Welch, Inside Sales Specialist, Nuclera
Nikhil Gupta
Nikhil Gupta
Chas Bountra
Chas Bountra
Lawrence Welch
Lawrence Welch

 

 

 

 

 

The event will also feature a panel discussion which will cover the upcoming areas of opportunity in drug discovery, the challenges and where future commercial success will be found. It will examine new processes and technology – how they can create efficiencies and expedite the drug discovery process.

DDW will be joined by the following panelists: Joanne Taylor, SVP Research, Gain Therapeutics; Dan Williams, CEO of SynaptixBio; Daniel Ives, CEO and Founder of Shift Bioscience; and Dr Richard Butt, Apollo Therapeutics’ Chief Scientific Officer.

The event is sponsored by Nuclera (lead sponsor) and Collaborative Drug Discovery (coffee break sponsor).

Register your interest to attend here.